India 2018

306 India 2018
hospital. The institute regularly organizes academic activities like CME
programmes, workshops, seminars and guest lectures. The hospital of the
institute provides clinical services to the patients from general and specialty
OPDs for skin diseases, GIT and hepato-billiary disorders, neurological
disorders, psychiatric and geriatric care.
(v) National Institute of Siddha, Chennai: It offers 06 post-graduate courses in
Siddha with intake capacity of 46 students, provides medical care and
undertakes research to promote and propagate the Siddha system of
medicine. A 160 bedded In-patient facility provide medical care in
accordance with respective PG Departments. The institute organises two
medical camps on every Saturday, one in rural area and the other in semiurban
area to provide free medical facilities to promote the Siddha Medicine
as well as community oriented approach to students.
New Autonomous Institutes
(i)
All India Institute of Ayurveda, New Delhi: It is conceived as an apex institute
for Ayurveda with 200 bed referral hospital. The Institute offers postgraduate
and Ph.D. courses in Ayurveda with intake capacity of 84 students
in 18 post-graduate courses. OPD is already operational in the Institute.
(ii) North Eastern Institute of Ayurveda & Homeopathy, Shillong: The project
consists of Ayurveda and homoeopathy colleges along with attached
hospitals of Ayurveda and Homoeopathy with a capacity of 100 and 50
beds respectively.
Research in AYUSH
The Government has set-up five autonomous research councils, namely, Central
Council for Research in Ayurvedic Sciences (CCRAS), Central Council for
Research in Yoga & Naturopathy (CCRYN), Central Council for Research in
Unani Medicines (CCRUM), Central Council for Research in Siddha (CCRS)
and Central Council for Research in Homoeopathy (CCRH) with the mandate
to under-take research in their respective system.Recently, for the management
of diabetes mellitus, the Central Council for Research in Ayurvedic
Sciences(CCRAS) has developed a formulation namely, AYUSH-82 from 05
Ayurvedic medicinal plants. The trials of the drug has shown significant
reduction in blood sugar level along with clinical improvement. No toxic effects
were noted during the trial. CCRAS has initiated action to commercialize
AYUSH-82.
In addition to its research work, the 81 institutes under the Council also
provide healthcare facilities. The CCRH through its programme namely,
Homoeopathy for Healthy Child enrolled 40,000 children with an aim to help
them during dentition period and treatment of disease.